4DMedical is an Australian company founded in 2012 that operates within the manufacturing sector, specifically focusing on medical devices and equipment. With an employee size ranging from 51 to 200, the company has a reported revenue of approximately $2.4 million. Its published documents indicate a commitment to addressing challenges in respiratory diagnosis, particularly in the context of the COVID-19 pandemic. A notable position paper discusses the delays in lung function testing, such as spirometry and plethysmography, which are critical for diagnosing chronic respiratory conditions like chronic obstructive pulmonary disease (COPD). The paper highlights the implications of these delays on patient health and safety, emphasizing the need for safer pulmonary testing methods. Furthermore, the document outlines the limitations of traditional lung imaging techniques, such as X-ray, in detecting early stages of lung disease. Overall, 4DMedical appears to be focused on enhancing diagnostic processes and patient outcomes in respiratory health through innovative approaches in medical technology.